CD8A and melanoma: Concordantly, immunohistochemical analysis of melanoma tumors treated with IM monotherapy also revealed the presence of HEVs, which we envisage contribute to the similarly robust CD8 T cell influx elicited in this very different tumor type (Figures S4H and S4I).